Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.

Shah, Ravi A; Asatryan, Babken; Dabbagh, Ghaith Sharaf; Aung, Nay; Khanji, Mohammed Y; Lopes, Luis R; van Duijvenboden, Stefan; Holmes, Anthony; Muser, Daniele; Landstrom, Andrew P; Lee, Aaron Mark; Arora, Pankaj; Semsarian, Christopher; Somers, Virend K; Owens, Anjali T; Munroe, Patricia B; Petersen, Steffen E; Chahal, C Anwar A (2022). Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants. Circulation, 146(2), pp. 110-124. American Heart Association 10.1161/CIRCULATIONAHA.121.058143

[img]
Preview
Text
CIRCULATIONAHA.121.058143.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (835kB) | Preview

BACKGROUND

There is a paucity of data regarding the phenotype of dilated cardiomyopathy (DCM) gene variants in the general population. We aimed to determine the frequency and penetrance of DCM-associated putative pathogenic gene variants in a general adult population, with a focus on the expression of clinical and subclinical phenotype, including structural, functional, and arrhythmic disease features.

METHODS

UK Biobank participants who had undergone whole exome sequencing, ECG, and cardiovascular magnetic resonance imaging were selected for study. Three variant-calling strategies (1 primary and 2 secondary) were used to identify participants with putative pathogenic variants in 44 DCM genes. The observed phenotype was graded DCM (clinical or cardiovascular magnetic resonance diagnosis); early DCM features, including arrhythmia or conduction disease, isolated ventricular dilation, and hypokinetic nondilated cardiomyopathy; or phenotype-negative.

RESULTS

Among 18 665 individuals included in the study, 1463 (7.8%) possessed ≥1 putative pathogenic variant in 44 DCM genes by the main variant calling strategy. A clinical diagnosis of DCM was present in 0.34% and early DCM features in 5.7% of individuals with putative pathogenic variants. ECG and cardiovascular magnetic resonance analysis revealed evidence of subclinical DCM in an additional 1.6% and early DCM features in an additional 15.9% of individuals with putative pathogenic variants. Arrhythmias or conduction disease (15.2%) were the most common early DCM features, followed by hypokinetic nondilated cardiomyopathy (4%). The combined clinical/subclinical penetrance was ≤30% with all 3 variant filtering strategies. Clinical DCM was slightly more prevalent among participants with putative pathogenic variants in definitive/strong evidence genes as compared with those with variants in moderate/limited evidence genes.

CONCLUSIONS

In the UK Biobank, ≈1 of 6 of adults with putative pathogenic variants in DCM genes exhibited early DCM features potentially associated with DCM genotype, most commonly manifesting with arrhythmias in the absence of substantial ventricular dilation or dysfunction.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Asatryan, Babken

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1524-4539

Publisher:

American Heart Association

Language:

English

Submitter:

Pubmed Import

Date Deposited:

22 Jun 2022 14:05

Last Modified:

18 Dec 2022 00:25

Publisher DOI:

10.1161/CIRCULATIONAHA.121.058143

PubMed ID:

35708014

Uncontrolled Keywords:

arrhythmias, cardiac cardiomyopathies death, sudden, cardiac genetic testing genetics penetrance

BORIS DOI:

10.48350/170791

URI:

https://boris.unibe.ch/id/eprint/170791

Actions (login required)

Edit item Edit item
Provide Feedback